Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 3:19 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | STATE STREET CORP STT | 4,410,403 5.52% | 694,873 (+18.70%) | View |
| 2022-02-10 5:37 pm Sale | 13G | MYRIAD GENETICS INC MYGN | EARNEST PARTNERS LLC | 6,316,365 7.9% | -415,064 (-6.17%) | View |
| 2022-02-10 08:27 am Purchase | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 9,149,521 11.46% | 852,657 (+10.28%) | View |
| 2022-02-04 09:21 am Purchase | 13G | MYRIAD GENETICS INC MYGN | WELLINGTON MANAGEMENT GROUP LLP | 4,325,775 5.42% | 2,639,175 (+156.48%) | View |
| 2022-01-27 1:59 pm Unchanged | 13G | MYRIAD GENETICS INC MYGN | BlackRock Inc. BLK | 14,684,787 18.4% | 0 (Unchanged) | View |
| 2022-01-25 6:45 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | BlackRock Inc. BLK | 14,684,787 18.4% | 2,182,867 (+17.46%) | View |
| 2021-02-16 4:03 pm Sale | 13G | MYRIAD GENETICS INC MYGN | D. E. SHAW & CO L.P. | 3,215,449 4.3% | -576,079 (-15.19%) | View |
| 2021-02-16 3:33 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | EARNEST PARTNERS LLC | 6,731,429 9% | 6,731,429 (New Position) | View |
| 2021-02-16 08:20 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 5,000,000 6.65% | 1,000,000 (+25.00%) | View |
| 2021-02-16 08:19 am Sale | 13G | MYRIAD GENETICS INC MYGN | STATE STREET CORP STT | 3,715,530 4.94% | -170,746 (-4.39%) | View |
| 2021-02-10 11:28 am Sale | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 8,296,864 11.03% | -23,710 (-0.28%) | View |
| 2021-01-25 4:49 pm Sale | 13G | MYRIAD GENETICS INC MYGN | BlackRock Inc. BLK | 12,501,920 16.6% | -250,199 (-1.96%) | View |
| 2020-07-07 06:20 am Sale | 13G | MYRIAD GENETICS INC MYGN | BAILLIE GIFFORD & CO | 0 0% | -4,046,168 (Position Closed) | View |
| 2020-06-22 10:01 am Purchase | 13G | MYRIAD GENETICS INC MYGN | Camber Capital Management LP | 4,000,000 5.37% | 2,500,000 (+166.67%) | View |
| 2020-06-15 4:11 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | D. E. SHAW & CO L.P. | 3,791,528 5.1% | 923,114 (+32.18%) | View |
| 2020-06-04 08:46 am Sale | 13G | MYRIAD GENETICS INC MYGN | BAILLIE GIFFORD & CO | 4,046,168 5.43% | -4,919,010 (-54.87%) | View |
| 2020-02-14 4:26 pm Sale | 13G | MYRIAD GENETICS INC MYGN | D. E. SHAW & CO L.P. | 2,868,414 3.9% | -1,054,438 (-26.88%) | View |
| 2020-02-14 08:19 am Purchase | 13G | MYRIAD GENETICS INC MYGN | STATE STREET CORP STT | 3,886,276 5.22% | 180,012 (+4.86%) | View |
| 2020-02-11 7:14 pm Sale | 13G | MYRIAD GENETICS INC MYGN | VANGUARD GROUP INC | 8,320,574 11.18% | -872,141 (-9.49%) | View |
| 2020-02-04 12:15 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | BlackRock Inc. BLK | 12,752,119 17.1% | 549,677 (+4.50%) | View |